We are delighted to be partnering with Blackford, the Enterprise AI platform and solutions provider, to offer the Aival Analysis Lab to healthcare providers globally via the Blackford Platform.

Platforms provide an important means to efficiently deploy and integrate AI solutions, with Blackford offering a broad portfolio of over 140 solutions. The Aival Analysis Lab will be available to Blackford customers to be able to compare and evaluate AI products, curate local image datasets, and monitor deployed AI products.

“We are pleased to partner with Aival and integrate their Analysis Lab into the Blackford AI Platform portfolio,” says Ben Panter, Founder and CEO of Blackford. “This collaboration allows us to enhance our support to healthcare providers who want to evaluate and monitor AI solutions, helping drive the adoption of AI, improving operational efficiencies across healthcare systems, and further advancing our mission to improve patient health around the world.” 

“We are delighted to bring the Aival Analysis Lab suite of software for AI assurance to the Blackford platform. We have long been impressed with Blackford’s focus on customer needs and commitment to trustworthy AI, as well as their expertise in implementing technological solutions. Through this partnership, we aim to offer customers greater transparency into the safety and effectiveness of AI products, and confidence in their choice and use over time. Together, we are looking forward to advancing our shared goal of unlocking the transformative value of AI that best serves the needs of healthcare providers and patients". Kanwal Bhatia, Founder & CEO of Aival. 

More information on the Blackford Enterprise AI Platform: https://blackfordanalysis.com/ and on our partnership here: https://info.blackfordanalysis.com/blog/blackford-partner-with-aival-analysis-lab